Deficiency of NEIL3 Enhances the Chemotherapy Resistance of Prostate Cancer

Acquired treatment resistance is an important cause of death in prostate cancer, and this study aimed to explore the mechanisms of chemotherapy resistance in prostate cancer. We employed castration-resistant prostate cancer (CRPC), neuroendocrine prostate cancer (NEPC), and chemotherapy-resistant pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yiwei, Xu, Liuyue, Shi, Shanshan, Wu, Sha, Meng, Ruijie, Chen, Huifang, Jiang, Zhenyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071437/
https://www.ncbi.nlm.nih.gov/pubmed/33921035
http://dx.doi.org/10.3390/ijms22084098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071437/
https://www.ncbi.nlm.nih.gov/pubmed/33921035
http://dx.doi.org/10.3390/ijms22084098

Ejemplares similares